Aveir VR LP Leadless Pacemaker Discussion
Medical Information Discussion - October 26, 2025
⚠️ IMPORTANT MEDICAL DISCLAIMER
This document contains educational information and discussion points from a conversation with Claude AI. This is NOT medical advice and should not replace consultation with qualified healthcare professionals. All medical decisions should be made in consultation with your cardiologist and electrophysiologist. This document is for personal reference only.
Patient Profile
- Age: 71 years old
- Device: Aveir VR LP (leadless pacemaker)
- Time since implant: 18 months
- Pacing burden: 100% ventricular pacing
- General health: Totally healthy, no other cardiac conditions
- Activity level: Competitive rowing athlete
- Recent echo: Perfect (normal LV function)
- NT-proBNP: 328 pg/mL (measured post-rowing race)
1. Nocturnal Discomfort with Aveir VR LP
Device-Related Causes
Phrenic Nerve Stimulation (Most Common)
- Right phrenic nerve runs close to RV pacing site
- Causes rhythmic diaphragmatic twitching or hiccup-like sensations
- More noticeable when lying down or in certain positions
- Occurs with each paced heartbeat
- Can disturb sleep significantly
Management Options:
- Device reprogramming to reduce output voltage
- Adjust pacing vector if available
- Positional changes during sleep
- Device repositioning (last resort due to procedural risks)
Key Point: Phrenic nerve stimulation does NOT damage the heart directly. It causes discomfort and should be addressed for quality of life, but it's not harmful to cardiac function.
Other Potential Causes
- Intercostal muscle stimulation from high output settings
- Cardiac arrhythmias (AF, PVCs)
- Heart failure symptoms (orthopnea, PND)
- Non-cardiac: sleep apnea, GERD, anxiety
2. Long-Term Effects of 100% RV Pacing
⚠️ Critical Understanding: 100% pacing burden represents maximum exposure to dyssynchronous cardiac activation and carries the highest risk for long-term complications.
Major Long-Term Risks
1. Pacing-Induced Cardiomyopathy (PIC)
- Occurs in 10-20% of patients with high RV pacing burden
- Progressive LV dysfunction from abnormal electrical activation
- Can develop over months to years
- Risk factors: pre-existing LV dysfunction, longer duration, apical location
2. Heart Failure Development
- New-onset HF risk: 10-15% over 5-10 years
- Symptoms: dyspnea, fatigue, edema, exercise intolerance
- Can be progressive if untreated
3. Atrial Fibrillation
- Increased risk with chronic RV pacing
- Atrial stretch from dyssynchrony
- Further worsens cardiac function
4. Mitral Regurgitation
- Dyssynchrony affects papillary muscle timing
- Can worsen progressively
- Contributes to heart failure symptoms
5. LV Remodeling
- Chamber dilation over time
- Wall thinning
- Reduced ejection fraction
- May be irreversible if prolonged
Why 100% RV Pacing is Problematic
- Electrical dyssynchrony: RV activates first, LV late (LBBB pattern)
- Mechanical consequences: Inefficient contraction, reduced cardiac output (10-20%)
- Abnormal wall stress: Uneven distribution leads to remodeling
- Increased oxygen demand: Less efficient work requires more energy
Risk Stratification
| Higher Risk Patients |
Lower Risk Patients |
| Pre-existing LV dysfunction (EF <50%) |
Normal baseline LV function |
| Longer pacing duration (many years) |
Younger age |
| RV apical pacing location |
RV septal pacing |
| Underlying cardiomyopathy |
No other cardiac disease |
| Older age with comorbidities |
Isolated conduction disease |
3. Life Expectancy with 100% Pacing
✓ Key Understanding: The pacemaker is LIFE-EXTENDING, not life-limiting. Without it, patients with complete heart block face sudden death or severe symptoms.
Factors That Determine Life Expectancy
1. Underlying Indication (Most Important)
- Idiopathic heart block: Near-normal life expectancy
- Age-related conduction disease: Depends on age and comorbidities
- Post-cardiac surgery/ablation: Generally good prognosis
- Ischemic heart disease: Depends on extent of CAD
- Structural heart disease: More guarded prognosis
2. Baseline Cardiac Function
- Normal EF (>50%): Excellent long-term outcomes
- Mild dysfunction (40-50%): Good with monitoring
- Moderate/severe (<40%): Higher mortality risk
3. Age and Comorbidities
- Younger patients (<65): Decades of expected survival
- Older patients (>75): Life expectancy more affected by age-related factors
- Comorbidities (HF, kidney disease, diabetes) affect outcomes more than pacing mode
Research Data on Life Expectancy
- Patients with normal LV function and isolated conduction disease: Near-normal life expectancy
- High RV pacing burden: 10-20% increased risk of HF hospitalization
- Development of PIC: Associated with worse outcomes if untreated
- Age-adjusted mortality in modern era: Quite favorable with appropriate monitoring
For a 71-Year-Old "Totally Healthy" Patient
This is a FAVORABLE scenario:
- Age 71 is relatively young in pacemaker terms
- No heart failure, coronary disease, or cardiac pathology
- Likely isolated conduction system disease
- Excellent long-term outcomes expected
Realistic Expectations:
- Average 71-year-old life expectancy: ~15 years
- Healthy 71-year-old: Potentially 15-20+ years
- With pacemaker for isolated conduction disease: Life expectancy approaches age-matched healthy population
Most Likely Outcome (80-90% probability):
- Lives many years (10-20+) with stable cardiac function
- Device functions well throughout battery life (8-15 years)
- Quality of life remains good
- Eventually needs battery replacement
- Dies of age-related causes, not pacemaker complications
Less Likely Scenario (10-20% probability):
- Develops gradual LV dysfunction from chronic pacing
- Detected on routine monitoring
- May need upgrade to CRT or conduction system pacing
- With proper management, outcomes still good
4. Monitoring Strategy
Essential Monitoring (Every 6 Months)
- Echocardiography: Track LV function, EF, chamber size, mitral regurgitation
- Device interrogation: Pacing burden, battery life, thresholds
- NT-proBNP levels: Early marker of cardiac strain
- Symptom assessment: Exercise tolerance, dyspnea, fatigue
Warning Signs Requiring Immediate Evaluation
- Declining ejection fraction (even 60% → 55%)
- New or worsening dyspnea
- Exercise intolerance or declining performance
- Peripheral edema
- Rising BNP levels (>50% increase from baseline)
- New mitral regurgitation or LV dilation
5. Left Bundle Branch Area Pacing (LBBAP) Consideration
The Leadless Device Dilemma
Key Challenge: Aveir VR LP cannot be upgraded to dual-chamber or CRT easily. Would require extraction and new transvenous system implantation.
Arguments FOR Switching to LBBAP
- Prevention vs. Treatment: 100% pacing = maximum risk; LBBAP eliminates dyssynchrony
- Superior Data: LBBAP shows lower heart failure rates and better LV function preservation
- Physiologic Pacing: More natural cardiac activation pattern
- Patient is Healthy: Good surgical candidate now; optimal time if going to do it
- Long-Term Perspective: Could live 15-20+ years; enough time to benefit
- Future Upgrade Harder: If LV dysfunction develops later, patient older and sicker
Arguments FOR Monitoring/Not Switching
- "If it ain't broke...": Device functioning well, patient stable
- 80-90% Do Fine: Most patients don't develop significant problems
- Procedural Risks: Extraction + new system = 5-8% complication risk
- Trading Device Types: Giving up leadless advantages (no leads, lower infection risk)
- Age Consideration: At 71, may not live long enough to see major benefits
- Lack of Evidence: No studies showing benefit of extracting functioning device
Procedural Risks at 18 Months Post-Implant
| Procedure Component |
Risk Level |
| Aveir extraction success |
90-95% |
| Major complications (perforation, tamponade) |
3-5% |
| LBBAP procedural success |
90-95% |
| Combined procedural risk |
5-8% |
| Death |
<0.5% |
Note: 18 months represents moderate encapsulation - not early (<6 months) but not late (>3-5 years).
6. NT-proBNP Results and Interpretation
Your Specific Result
- NT-proBNP Level: 328 pg/mL
- Timing: Measured AFTER a rowing race
- Echocardiogram: Perfect (normal LV function)
Understanding BNP
What is NT-proBNP?
- Hormone released by heart ventricles under stress/strain
- Elevated in heart failure, LV dysfunction, volume overload
- Early marker of cardiac dysfunction - often rises BEFORE echo changes
- Useful for tracking trends over time
Normal Values
- Normal for age <75: <125-150 pg/mL
- Mild elevation: 125-450 pg/mL
- Moderate: 450-900 pg/mL
- Severe: >900 pg/mL
⚠️ CRITICAL CONTEXT: Exercise Effect on BNP
Your 328 measurement was taken POST-ROWING RACE!
Why This Changes Everything:
- Acute exercise causes 2-4x elevation in BNP
- Remains elevated for hours post-exercise
- Rowing race = maximal cardiovascular stress
- 328 pg/mL post-race ≠ resting 328!
Estimated True Resting BNP:
- If 328 represents 2-3x elevation from exercise
- Resting BNP likely: 100-160 pg/mL
- This would be normal or near-normal for age 71
✓ VERY REASSURING CLINICAL FINDINGS
You are 71 years old and competing in ROWING RACES!
- Requires excellent cardiovascular fitness
- High functional capacity
- Heart handling 100% pacing well enough to race competitively
- Completely inconsistent with developing heart failure
If you had significant pacing-induced cardiomyopathy:
- You wouldn't be able to row competitively
- You'd have progressive exercise intolerance
- You'd be symptomatic
- Your performance would have declined
Your ability to race is STRONG EVIDENCE your heart is compensating well!
Action Plan for Accurate BNP Assessment
- Get Proper Resting Baseline BNP:
- No rowing or intense exercise for 48 hours before test
- Morning draw, fasted
- Well-hydrated, rested
- Sitting quietly 10-15 minutes before blood draw
- Compare to Functional Capacity:
- Low BNP + rowing competitively = excellent
- Exercise performance is the best clinical marker
- Establish Monitoring Schedule:
- Resting BNP every 6 months
- Track trends over time (more important than single value)
- Rising trend = warning sign, even if still "normal"
BNP Interpretation Guidelines
| BNP Pattern |
Interpretation |
Action |
| Stable/declining |
Reassuring - LV handling pacing well |
Continue routine monitoring |
| 25-50% increase from baseline |
Warning sign even if "normal range" |
Earlier/more detailed echo |
| >2x baseline or >400 pg/mL |
Significant elevation |
Urgent echo, consider upgrade evaluation |
7. Current Clinical Assessment and Recommendations
Overall Patient Profile Summary
- ✓ Age: 71 - relatively young in pacemaker terms
- ✓ General Health: Totally healthy, no comorbidities
- ✓ Device: Aveir VR LP, 18 months post-implant
- ✓ Pacing Burden: 100% (high risk factor)
- ✓ Echo: Perfect - no structural changes or dysfunction
- ✓ BNP: 328 post-race (likely 100-160 at rest - normal/near-normal)
- ✓ Functional Capacity: EXCELLENT - competitive rowing athlete
- ✓ Symptoms: None
Risk Assessment
Favorable Factors:
- Excellent functional capacity (best predictor of outcomes)
- Perfect echo with normal LV function
- No symptoms of heart failure
- Isolated conduction disease (no other cardiac pathology)
- Active lifestyle maintained
Risk Factors:
- 100% pacing burden (10-20% risk of PIC over 5-10 years)
- 18 months of dyssynchronous pacing already accumulated
- Cannot easily upgrade to CRT if needed (leadless device)
Current Recommendation: Close Monitoring with Low Threshold for Intervention
Why Monitoring is Appropriate Now:
- Exercise capacity is excellent - most important clinical finding
- Echo is perfect - no structural changes yet
- BNP measurement was confounded - need proper resting value
- Functional status beats lab values - you're competing in races!
- 80-90% of patients tolerate 100% pacing - you may be in this group
- Procedural risk is real - 5-8% complication risk with LBBAP switch
Comprehensive Monitoring Plan
Every 6 Months:
- Echocardiogram (comprehensive LV assessment)
- NT-proBNP (resting, no exercise 48 hours prior)
- Device interrogation
- Clinical symptom assessment
Functional Monitoring (Ongoing):
- Track rowing performance and times
- Monitor exercise tolerance and recovery
- Note any decline in performance
- This is your best "stress test"!
Between Visits - Watch For:
- New dyspnea or shortness of breath
- Exercise intolerance or declining performance
- Unusual fatigue
- Leg swelling
- Any symptoms that concern you
Intervention Triggers - When to Consider LBBAP Switch
Act if ANY of these occur:
- Resting BNP truly elevated (>200-250 pg/mL) or rising >50%
- Echo shows ANY decline (even 60% → 55% EF)
- New LV dilation or mitral regurgitation
- Declining exercise performance or rowing times
- Development of symptoms (dyspnea, fatigue, edema)
- Strong patient preference for optimization after full risk discussion
Immediate Action Items
- Schedule proper resting NT-proBNP:
- No exercise 48 hours prior
- Morning, fasted
- This establishes your true baseline
- Continue your rowing and active lifestyle:
- Your functional capacity is the best monitor
- Track performance over time
- Declining performance = early warning
- Keep all cardiology appointments:
- Echo and BNP every 6 months minimum
- Device checks every 3-6 months
- Consider consultation with LBBAP center:
- Get expert opinion on extraction risk at 18 months
- Understand options if intervention becomes needed
- No commitment, just information gathering
- Create monitoring log:
- Track BNP values, echo EF, symptoms over time
- Note rowing performance and times
- Trends will guide decisions
8. Key Takeaways
✓ The Good News
- Your heart is handling 100% pacing remarkably well
- Excellent functional capacity (competitive rowing!) is the best prognostic indicator
- Perfect echo shows no structural damage yet
- Post-exercise BNP of 328 likely reflects normal resting value
- You're "totally healthy" otherwise - major advantage
- Life expectancy likely 15-20+ years with proper monitoring
- 80-90% chance you'll do fine long-term with current device
📊 Important Monitoring Points
- 100% pacing does carry 10-20% risk of eventual LV dysfunction
- Close monitoring every 6 months is essential
- Get proper resting BNP (no exercise 48 hours prior)
- Your exercise performance is your best early warning system
- Early detection allows for intervention before permanent damage
⚠️ Red Flags Requiring Action
- Declining exercise capacity or rowing performance
- Rising BNP trend (>50% increase)
- Any decline in EF on echo
- New symptoms (dyspnea, fatigue, edema)
- New mitral regurgitation or LV dilation
LBBAP Decision Framework
Consider LBBAP switch if:
- Any signs of early LV dysfunction develop
- Resting BNP confirmed elevated and rising
- Strong patient preference for prevention after informed discussion
- Access to high-volume LBBAP center with excellent outcomes
Continue monitoring if:
- Echo remains perfect
- Resting BNP normal/stable
- Exercise performance maintained or improving
- No symptoms
- Patient prefers avoiding procedural risk
Bottom Line for Your Specific Case
You are in an excellent position:
- The fact that you're competing in rowing races at age 71 with 100% pacing is REMARKABLE
- This functional capacity is much more reassuring than any lab value
- Your perfect echo confirms no damage has occurred yet
- The elevated BNP in context (post-race) is likely not concerning
- With close monitoring, you can catch any problems very early
- Your prognosis is quite good - likely many active years ahead
Keep doing what you're doing:
- Stay active with rowing - it's the best medicine
- Keep all monitoring appointments
- Get proper resting BNP to establish baseline
- Don't worry excessively - you're doing great
- Trust that early detection will allow timely intervention if needed
9. Questions to Discuss with Your Cardiologist
At Your Next Appointment:
- BNP Assessment:
- "Can we get a resting BNP measurement (no exercise for 48 hours prior) to establish my true baseline?"
- "What do you think about the 328 value in context of it being post-rowing race?"
- Monitoring Plan:
- "Can we schedule echo and BNP every 6 months given my 100% pacing burden?"
- "What specific changes would trigger consideration for device upgrade?"
- Current Function:
- "What was my exact EF on the most recent echo?"
- "Any signs of dyssynchrony, LV dilation, or mitral regurgitation?"
- "How does my LV function compare to baseline at implant?"
- Future Planning:
- "If I develop LV dysfunction in the future, what would be the upgrade options?"
- "Have you referred patients for Left Bundle Branch Area Pacing (LBBAP)?"
- "Would a consultation with an LBBAP-experienced electrophysiologist be worthwhile?"
- Activity Level:
- "Is my current rowing activity level appropriate with 100% pacing?"
- "Should I be monitoring for any specific symptoms during training?"
10. Resources and References
Key Points for Further Discussion
- Pacing-Induced Cardiomyopathy (PIC): Well-recognized complication of chronic RV pacing
- Conduction System Pacing (CSP): Includes His bundle pacing and LBBAP - more physiologic alternatives
- Cardiac Resynchronization Therapy (CRT): Traditional biventricular pacing for heart failure
- Leadless Pacemaker Technology: Newer technology with pros/cons vs. traditional leads
Topics to Research with Your Medical Team
- Left Bundle Branch Area Pacing (LBBAP) outcomes and experience at local centers
- Leadless pacemaker extraction procedures and risks
- Latest guidelines on managing high ventricular pacing burden
- Role of BNP in monitoring pacemaker patients
Final Disclaimer and Important Notes
This Document:
- Contains educational information and discussion points only
- Is NOT a substitute for professional medical advice
- Should be shared with your healthcare team for their review
- Reflects information as of October 26, 2025
- Is based on a conversation with Claude AI assistant
All Medical Decisions Should Be Made:
- In consultation with your cardiologist and electrophysiologist
- Based on your complete medical history and examination
- With full understanding of risks, benefits, and alternatives
- According to current medical guidelines and standards of care
Emergency Warning: If you experience chest pain, severe shortness of breath, loss of consciousness, or other emergency symptoms, seek immediate medical attention by calling emergency services (911 in US).
Document created: October 26, 2025
For personal medical records - Not for distribution